Evolution In Prostate Cancer Diagnostics Creates New Opportunities For Medtech
Fuld + Company
In the US, prostate cancer remains a challenge for men’s health, with approximately 174,650 new cases expected in 2019, third […]
Laura Ruth, Ph.D. is a Director with Fuld + Company’s Global Health + Life Science Practice. In addition to leading a wide array of projects at Fuld, Dr. Ruth has published several thought leadership pieces on the topics of competitive intelligence, physician versus pharmacist vaccinators, and generic medical devices. She also has received Competitive Intelligence Professional (CIP™) Certificate. Prior to joining Fuld, Dr. Ruth was an independent medical, science, and technology writer and consultant covering a wide range of science, technology, business, policy, and regulatory topics. Dr. Ruth holds a B.S. in chemistry from MIT and a Ph.D. in biological X-ray crystallography from the University of Pennsylvania.